Concord Medical Co., Ltd. (TPEX:6518)
Taiwan
· Delayed Price · Currency is TWD 26.60
0.00 (0.00%)
Mar 9, 2026, 2:31 PM CST
Concord Medical Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 887 | 860 | 853 | 787 | 450 | 350 | Upgrade
|
| Market Cap Growth | 2.31% | 0.78% | 8.48% | 74.81% | 28.57% | -1.69% | Upgrade
|
| Enterprise Value | 817 | 783 | 779 | 693 | 643 | 610 | Upgrade
|
| Last Close Price | 26.60 | 24.62 | 23.49 | 20.91 | 15.68 | 11.82 | Upgrade
|
| PE Ratio | 16.22 | 17.35 | 19.96 | 15.53 | 13.08 | 17.70 | Upgrade
|
| PS Ratio | 0.98 | 0.97 | 1.02 | 0.89 | 0.61 | 0.43 | Upgrade
|
| PB Ratio | 1.28 | 1.23 | 1.25 | 1.11 | 0.71 | 0.68 | Upgrade
|
| P/TBV Ratio | 1.29 | 1.24 | 1.26 | 1.18 | 0.71 | 0.72 | Upgrade
|
| P/FCF Ratio | 7.86 | 11.60 | 34.07 | 6.72 | 3.89 | - | Upgrade
|
| P/OCF Ratio | 4.75 | 5.78 | 7.54 | 5.09 | 3.28 | 4.16 | Upgrade
|
| EV/Sales Ratio | 0.90 | 0.88 | 0.94 | 0.78 | 0.87 | 0.75 | Upgrade
|
| EV/EBITDA Ratio | 5.35 | 5.46 | 5.93 | 5.00 | 5.75 | 5.67 | Upgrade
|
| EV/EBIT Ratio | 12.06 | 12.87 | 14.24 | 10.70 | 17.15 | 21.72 | Upgrade
|
| EV/FCF Ratio | 7.24 | 10.56 | 31.11 | 5.92 | 5.56 | - | Upgrade
|
| Debt / Equity Ratio | 0.34 | 0.29 | 0.30 | 0.25 | 0.30 | 0.62 | Upgrade
|
| Debt / EBITDA Ratio | 1.53 | 1.39 | 1.55 | 1.29 | 1.42 | 2.44 | Upgrade
|
| Debt / FCF Ratio | 2.08 | 2.72 | 8.25 | 1.55 | 1.65 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.10 | -0.17 | -0.17 | -0.23 | -0.01 | 0.51 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.47 | -0.83 | -0.86 | -1.20 | -0.08 | 2.42 | Upgrade
|
| Net Debt / FCF Ratio | -0.63 | -1.61 | -4.53 | -1.42 | -0.07 | -27.13 | Upgrade
|
| Asset Turnover | 0.78 | 0.77 | 0.72 | 0.79 | 0.68 | 0.74 | Upgrade
|
| Inventory Turnover | 200.54 | 238.64 | 167.10 | 100.25 | 109.78 | 230.07 | Upgrade
|
| Quick Ratio | 1.80 | 2.18 | 2.23 | 2.24 | 1.93 | 1.32 | Upgrade
|
| Current Ratio | 1.84 | 2.21 | 2.26 | 2.27 | 1.99 | 1.41 | Upgrade
|
| Return on Equity (ROE) | 8.03% | 7.19% | 6.14% | 7.51% | 5.98% | 3.89% | Upgrade
|
| Return on Assets (ROA) | 3.63% | 3.28% | 2.94% | 3.58% | 2.16% | 1.60% | Upgrade
|
| Return on Invested Capital (ROIC) | 8.65% | 8.43% | 7.71% | 8.70% | 4.30% | 2.79% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.90% | 6.90% | 6.30% | 7.40% | 4.60% | 3.50% | Upgrade
|
| Earnings Yield | 6.17% | 5.76% | 5.01% | 6.44% | 7.64% | 5.65% | Upgrade
|
| FCF Yield | 12.72% | 8.62% | 2.94% | 14.89% | 25.70% | -2.74% | Upgrade
|
| Dividend Yield | 4.04% | 4.47% | 4.26% | 4.78% | 3.19% | 3.38% | Upgrade
|
| Payout Ratio | 66.99% | 67.24% | 77.98% | 32.90% | 29.07% | 50.57% | Upgrade
|
| Buyback Yield / Dilution | -0.06% | -0.07% | -0.17% | -33.03% | -0.22% | 0.05% | Upgrade
|
| Total Shareholder Return | 3.98% | 4.39% | 4.09% | -28.25% | 2.97% | 3.44% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.